Season 8 · Episode 7
S8 Ep7: Blum Highlights Implications of CA-125 Levels in Renal Medullary Carcinoma
OncLive® On Air · OncLive® On Air
December 19, 202222m 46s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Blum discusses renal medullary carcinoma, the lack of approved systemic therapy for these patients, and findings showing a correlation between CA-125 levels and increased tumor burden and treatment response in this disease.